Objective
"Recent advances in clinical genetic studies of epilepsies have identified a steadily growing number of mutations in new candidate genes, creating a need for an effective approach to rapidly provide functional data as to their in vivo function. Furthermore, there is an urgent need to create new, cost- and time-effective animal models which successfully mimic genetic epilepsies in humans, as well as efficient drug discovery approaches to identify compounds useful in the management of these diseases. Here, using established genetic methods, loss- and gain-of-function zebrafish epilepsy models for gene variants recently identified to cause severe, drug-resistant epileptic encephalopathies (EE) will be created. Using a multidisciplinary ""deep-phenotyping"" strategy of pharmacological profiling (i.e. assessment of antiepileptic drugs (AEDs) with known mechanisms of action), high-throughput analysis of locomotor activity and seizure-like behavior, electroencephalographic recordings, histopathological analysis of zebrafish mutant brains, single-cell RNA expression profiling and high-resolution (SPIM) Ca2+ imaging analysis of brain activity, these models will be fully characterized and validated. Finally, a large-scale screen using a library of synthetic small molecules, drug-like natural products and FDA-approved drugs to identify compounds with antiepileptic activity will be performed in one of these models. The main objective of this project is to create and validate new zebrafish models of epilepsy, which will provide both new insights into the mechanisms of epileptogenesis in vivo and indicate potentially novel entry routes for therapeutic intervention."
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences basic medicine pharmacology and pharmacy drug discovery
- medical and health sciences basic medicine neurology epilepsy
- natural sciences biological sciences genetics mutation
- natural sciences biological sciences genetics RNA
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.1.3. - EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.1.3.2. - Nurturing excellence by means of cross-border and cross-sector mobility
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
MSCA-IF-EF-ST - Standard EF
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-MSCA-IF-2017
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
0313 Oslo
Norway
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.